Correction to: Nature Biotechnology https://doi.org/10.1038/s41587-022-01637-z, published online 19 January 2023.
In the version of this article initially published, the Acknowledgements did not include thanks for research support from the Myasthenia Gravis Foundation of America Nancy Law Impact Award as has now been amended in the HTML and PDF versions of the article.
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Oh, S., Mao, X., Manfredo-Vieira, S. et al. Author Correction: Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cells. Nat Biotechnol 42, 1923 (2024). https://doi.org/10.1038/s41587-024-02502-x
Published:
Issue date:
DOI: https://doi.org/10.1038/s41587-024-02502-x
